DK231088D0
(da)
*
|
1988-04-28 |
1988-04-28 |
Ferrosan As |
Piperidinforbindelser, deres fremstilling og anvendelse
|
IE66332B1
(en)
*
|
1986-11-03 |
1995-12-27 |
Novo Nordisk As |
Piperidine compounds and their preparation and use
|
DK58291D0
(da)
*
|
1991-04-02 |
1991-04-02 |
Novo Nordisk As |
Krystalinsk stof og dets fremstilling
|
GB9209687D0
(en)
*
|
1992-05-06 |
1992-06-17 |
Smithkline Beecham Plc |
Novel process
|
US5258517A
(en)
*
|
1992-08-06 |
1993-11-02 |
Sepracor, Inc. |
Method of preparing optically pure precursors of paroxetine
|
US5276042A
(en)
*
|
1993-04-16 |
1994-01-04 |
Crenshaw Roger T |
Treatment of premature ejaculation
|
EP0639568A1
(en)
*
|
1993-08-19 |
1995-02-22 |
Novo Nordisk A/S |
Piperidine compounds, their preparation and use in the treatment of neurodegenerative disorders
|
GB9325644D0
(en)
*
|
1993-12-15 |
1994-02-16 |
Smithkline Beecham Plc |
Novel formulation
|
US20020086053A1
(en)
*
|
1993-12-15 |
2002-07-04 |
Smithkline Beecham Plc |
Formulations, tablets of paroxetine and process to prepare them
|
ES2102295B1
(es)
*
|
1994-03-18 |
1998-04-01 |
Ferrer Int |
Nuevos compuestos derivados de la n-benzoilmetil-piperidina.
|
AR001982A1
(es)
*
|
1995-02-06 |
1998-01-07 |
Smithkline Beecham Plc |
Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
|
US5856493A
(en)
*
|
1995-02-06 |
1999-01-05 |
Smithkline Beecham Corporation |
Process for making novel form of paroxeting hydrochloride anhydrate
|
GB2297550C2
(en)
*
|
1995-02-06 |
1997-04-09 |
Smithkline Beecham Plc |
Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
|
ES2149726B1
(es)
*
|
1995-02-06 |
2001-06-16 |
Smithkline Beecham Plc |
Nuevos compuestos de paroxetina.
|
GB9502297D0
(en)
|
1995-02-06 |
1995-03-29 |
Smithkline Beecham Plc |
Novel compound
|
US6548084B2
(en)
*
|
1995-07-20 |
2003-04-15 |
Smithkline Beecham Plc |
Controlled release compositions
|
GB9605828D0
(en)
*
|
1996-03-20 |
1996-05-22 |
Smithkline Beecham Plc |
Treatment method
|
CA2206592A1
(en)
*
|
1996-05-30 |
1997-11-30 |
Shu-Zhong Wang |
Method of producing amorphous paroxetine hydrochloride
|
JP3882224B2
(ja)
|
1996-05-31 |
2007-02-14 |
旭硝子株式会社 |
パロキセチンの製造方法
|
US5965555A
(en)
*
|
1996-06-07 |
1999-10-12 |
Hoechst Aktiengesellschaft |
Xanthine compounds having terminally animated alkynol side chains
|
EP0812827B1
(en)
|
1996-06-13 |
2009-09-02 |
Sumitomo Chemical Company, Limited |
Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation
|
HU221921B1
(hu)
*
|
1996-07-08 |
2003-02-28 |
Richter Gedeon Vegyészeti Gyár Rt. |
N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
|
WO1998002556A2
(en)
*
|
1996-07-15 |
1998-01-22 |
Smithkline Beecham Plc |
Screening for and use of an esterase for a stereospecific resolution
|
US5672612A
(en)
*
|
1996-09-09 |
1997-09-30 |
Pentech Pharmaceuticals, Inc. |
Amorphous paroxetine composition
|
US6638948B1
(en)
*
|
1996-09-09 |
2003-10-28 |
Pentech Pharmaceuticals, Inc. |
Amorphous paroxetine composition
|
CA2193939C
(en)
*
|
1996-12-24 |
2002-02-12 |
K.S. Keshava Murthy |
Useful form of anhydrous paroxetine hydrochloride
|
DE29724281U1
(de)
*
|
1997-06-10 |
2000-08-10 |
Synthon Bv |
4-Phenylpiperidin-Verbindungen
|
US5955475A
(en)
*
|
1997-06-30 |
1999-09-21 |
Endo Pharmaceuticals Inc. |
Process for manufacturing paroxetine solid dispersions
|
GB9726907D0
(en)
*
|
1997-12-19 |
1998-02-18 |
Smithkline Beecham Plc |
Novel compounds
|
EP1053234A1
(en)
*
|
1998-02-06 |
2000-11-22 |
Smithkline Beecham Plc |
Salts of paroxetine
|
CA2323896A1
(en)
*
|
1998-03-16 |
1999-09-23 |
Andrew Simon Craig |
Crystalline form of paroxetine
|
AU2003200534B2
(en)
*
|
1998-03-24 |
2004-12-02 |
Smithkline Beecham Plc |
Paroxetine compositions
|
US6699882B2
(en)
|
1998-03-24 |
2004-03-02 |
Smithkline Beecham P.L.C. |
Paroxetine compositions
|
GB9806312D0
(en)
*
|
1998-03-24 |
1998-05-20 |
Smithkline Beecham Plc |
Novel formulations
|
GB9808896D0
(en)
*
|
1998-04-25 |
1998-06-24 |
Smithkline Beecham Plc |
Novel compound
|
GB9808894D0
(en)
*
|
1998-04-25 |
1998-06-24 |
Smithkline Beecham Plc |
Novel compound
|
GB9812941D0
(en)
*
|
1998-06-16 |
1998-08-12 |
Smithkline Beecham Plc |
Method of treatment
|
US6300343B1
(en)
|
1998-06-16 |
2001-10-09 |
Smithkline Beecham Corporation |
Method of treatment
|
CH689805A8
(fr)
*
|
1998-07-02 |
2000-02-29 |
Smithkline Beecham Plc |
Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
|
GB9814316D0
(en)
*
|
1998-07-02 |
1998-09-02 |
Smithkline Beecham Plc |
Novel compounds
|
ES2138937B1
(es)
|
1998-07-07 |
2000-10-01 |
Medichem Sa |
Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
|
EP1100796B1
(en)
*
|
1998-08-07 |
2003-05-02 |
SmithKline Beecham plc |
Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
|
EP1102764A1
(en)
*
|
1998-08-08 |
2001-05-30 |
Smithkline Beecham Plc |
Paroxetine salts
|
GB9824298D0
(en)
*
|
1998-11-05 |
1998-12-30 |
Smithkline Beecham Plc |
Novel process
|
GB9826175D0
(en)
*
|
1998-11-28 |
1999-01-20 |
Smithkline Beecham Plc |
Novel process
|
GB9826176D0
(en)
*
|
1998-11-28 |
1999-01-20 |
Smithkline Beecham Plc |
Novel process
|
GB9826242D0
(en)
*
|
1998-11-30 |
1999-01-20 |
Smithkline Beecham Plc |
Novel process
|
EP1135383B1
(en)
*
|
1998-11-30 |
2003-12-03 |
SmithKline Beecham plc |
Mixed paroxetine propan-2-ol solvates
|
GB9826180D0
(en)
*
|
1998-11-30 |
1999-01-20 |
Smithkline Beecham Plc |
Novel process
|
GB9826171D0
(en)
*
|
1998-11-30 |
1999-01-20 |
Smithkline Beecham Plc |
Novel compounds
|
GB9826178D0
(en)
*
|
1998-11-30 |
1999-01-20 |
Smithkline Beecham Plc |
Novel process
|
GB9827387D0
(en)
*
|
1998-12-11 |
1999-02-03 |
Smithkline Beecham Plc |
Novel process
|
GB9828779D0
(en)
*
|
1998-12-29 |
1999-02-17 |
Smithkline Beecham Plc |
Novel process
|
GB9828780D0
(en)
*
|
1998-12-29 |
1999-02-17 |
Smithkline Beecham Plc |
Novel process
|
GB9828781D0
(en)
*
|
1998-12-29 |
1999-02-17 |
Smithkline Beecham Plc |
Novel process
|
GB9828767D0
(en)
*
|
1998-12-29 |
1999-02-17 |
Smithkline Beecham Plc |
Novel process
|
ATE311883T1
(de)
*
|
1999-03-12 |
2005-12-15 |
Aesica Pharmaceuticals Ltd |
Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
|
FR2791345B1
(fr)
*
|
1999-03-26 |
2001-05-04 |
Adir |
Nouveaux derives du benzo[3,4]cyclobuta[1,2-c]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US6245782B1
(en)
|
1999-05-17 |
2001-06-12 |
Heartdrug Research L.L.C. |
Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
|
GB9914583D0
(en)
*
|
1999-06-22 |
1999-08-25 |
Smithkline Beecham Plc |
Novel process
|
GB9914585D0
(en)
*
|
1999-06-22 |
1999-08-25 |
Smithkline Beecham Plc |
Novel process
|
PT1109806E
(pt)
|
1999-07-01 |
2004-02-27 |
Italfarmaco Spa |
Complexos de paroxetina com ciclodextrinas ou derivados de ciclodextrinas
|
GB9916187D0
(en)
*
|
1999-07-09 |
1999-09-08 |
Smithkline Beecham Plc |
Novel process
|
GB9919052D0
(en)
*
|
1999-08-12 |
1999-10-13 |
Smithkline Beecham Plc |
Novel compound composition and process
|
GB9923446D0
(en)
*
|
1999-10-04 |
1999-12-08 |
Smithkline Beecham Plc |
Novel process
|
US6503927B1
(en)
|
1999-10-28 |
2003-01-07 |
Pentech Pharmaceuticals, Inc. |
Amorphous paroxetine composition
|
GB0003232D0
(en)
*
|
2000-02-11 |
2000-04-05 |
Smithkline Beecham Plc |
Novel composition
|
HU226912B1
(en)
*
|
2000-04-07 |
2010-03-01 |
Richter Gedeon Nyrt |
New paroxetin salt and medicament containing it
|
EP1284729A4
(en)
*
|
2000-04-13 |
2007-12-19 |
Mayo Foundation |
REDUCTION AGENTS OF A (BETA) 42
|
US6660298B1
(en)
*
|
2000-07-27 |
2003-12-09 |
Pentech Pharmaceuticals, Inc. |
Paroxetine tablets and capsules
|
US20030109577A1
(en)
*
|
2000-10-27 |
2003-06-12 |
Ken Liljegren |
Pharmaceutical composition containing citalopram
|
DE20100529U1
(de)
*
|
2001-01-11 |
2001-05-10 |
Synthon Bv |
Pharmazeutische Tablette umfassend Paroxetinmesylat
|
US6610326B2
(en)
*
|
2001-02-16 |
2003-08-26 |
Andrx Corporation |
Divalproex sodium tablets
|
US6720003B2
(en)
*
|
2001-02-16 |
2004-04-13 |
Andrx Corporation |
Serotonin reuptake inhibitor formulations
|
NL1017421C2
(nl)
|
2001-02-21 |
2002-01-15 |
Synthon Bv |
Werkwijze voor het vervaardigen van paroxetine.
|
US6645946B1
(en)
|
2001-03-27 |
2003-11-11 |
Pro-Pharmaceuticals, Inc. |
Delivery of a therapeutic agent in a formulation for reduced toxicity
|
US6930186B2
(en)
|
2001-06-13 |
2005-08-16 |
Teva Pharmacetical Industries Ltd. |
Process for the preparation of paroxetine substantially free of alkoxy impurities
|
IL159280A0
(en)
*
|
2001-06-14 |
2004-06-01 |
Teva Pharma |
A process for preparing paroxetine hcl which limits formation of pink colored compounds
|
MEP2108A
(xx)
|
2001-07-31 |
2010-02-10 |
Lundbeck & Co As H |
Kristalni sastav koji sadrži escitalopram
|
CA2456233A1
(en)
*
|
2001-08-02 |
2003-03-13 |
Spurcourt Limited |
Paroxetine isethionate salt, process of preparation and use in the treatment of depression
|
JP2005501066A
(ja)
*
|
2001-08-09 |
2005-01-13 |
スミスクライン ビーチャム パブリック リミテッド カンパニー |
パロキセチンおよび医薬上許容されるグリチルリチン酸塩を含む組成物
|
AU2002330771A1
(en)
*
|
2001-10-22 |
2003-06-10 |
Synthon B.V. |
N-formyl derivatives of paroxetine
|
WO2003057150A2
(en)
*
|
2001-12-28 |
2003-07-17 |
Teva Pharmaceutical Industries Ltd. |
A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
|
JP2005524656A
(ja)
*
|
2002-02-22 |
2005-08-18 |
テバ ファーマシューティカル インダストリーズ リミティド |
新規中間物質を用いるパロキセチンの調製
|
EP2316468A1
(en)
|
2002-02-22 |
2011-05-04 |
Shire LLC |
Delivery system and methods for protecting and administering dextroamphetamine
|
US6956121B2
(en)
|
2002-03-01 |
2005-10-18 |
Teva Pharmaceutical Industries Ltd. |
Preparation of paroxetine involving novel intermediates
|
UA77536C2
(en)
*
|
2002-07-03 |
2006-12-15 |
Lundbeck & Co As H |
Secondary aminoaniline piperidines as mch1 antagonists and their use
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
JP4394004B2
(ja)
*
|
2002-09-19 |
2010-01-06 |
住友化学株式会社 |
結晶析出方法
|
BR0314596A
(pt)
*
|
2002-09-19 |
2005-08-09 |
Sumitomo Chemical Co |
Processo para a produção de hidrato de cloridrato de paroxetina
|
US20040220153A1
(en)
*
|
2002-09-24 |
2004-11-04 |
Jost-Price Edward Roydon |
Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
|
WO2004071431A2
(en)
*
|
2003-02-05 |
2004-08-26 |
Myriad Genetics, Inc. |
Method and composition for treating neurodegenerative disorders
|
EP1507774A1
(en)
*
|
2003-03-12 |
2005-02-23 |
Biogal Gyogyszergyar Rt. |
Processes for preparation of polymorphic forms of desloratadine
|
US20060135547A1
(en)
*
|
2003-03-12 |
2006-06-22 |
Toth Zoltan G |
Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
|
KR20060040676A
(ko)
*
|
2003-07-11 |
2006-05-10 |
미리어드 제네틱스, 인크. |
알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형
|
PL1691811T3
(pl)
|
2003-12-11 |
2014-12-31 |
Sunovion Pharmaceuticals Inc |
Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
|
US20050154020A1
(en)
*
|
2004-01-14 |
2005-07-14 |
Synaptic Pharmaceutical Corporation |
4-Aryl piperidines
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
US20070293538A1
(en)
*
|
2004-04-13 |
2007-12-20 |
Myriad Genetics, Incorporated |
Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
|
US20050233010A1
(en)
*
|
2004-04-19 |
2005-10-20 |
Satow Philip M |
Lithium combinations, and uses related thereto
|
US20050252144A1
(en)
*
|
2004-04-29 |
2005-11-17 |
Macdonald Robert A |
Veneers for walls, retaining walls and the like
|
US20050266082A1
(en)
*
|
2004-05-26 |
2005-12-01 |
Patel Satishkumar A |
Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
|
BRPI0514303A
(pt)
*
|
2004-08-11 |
2008-06-10 |
Myriad Genetics Inc |
composição farmacêutica e método para tratar distúrbios neurodegenerativos
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
EP1778183B1
(en)
*
|
2004-08-18 |
2018-06-27 |
Synthon B.V. |
Liquid paroxetine compositions
|
US20060039975A1
(en)
*
|
2004-08-20 |
2006-02-23 |
Zalman Vilkov |
Paroxetine formulations
|
KR100672184B1
(ko)
*
|
2004-09-21 |
2007-01-19 |
주식회사종근당 |
파록세틴의 콜린산 또는 콜린산 유도체 염
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
DE102004056398A1
(de)
*
|
2004-11-23 |
2006-05-24 |
Bayer Materialscience Ag |
Hydrolysestabile, hydrophobe, lösemittelfreie Polyole
|
US20060216345A1
(en)
*
|
2005-03-24 |
2006-09-28 |
Sun Pharmaceutical Industries Limited |
Oral pharmaceutical composition including paroxetine
|
DE602006002650D1
(de)
*
|
2005-05-26 |
2008-10-23 |
Apotecnia S A |
Verfahren zur Herstellung von Paroxetin Hydrochlorid Hemihydrat
|
US20070015832A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Myriad Genetics, Incorporated |
Methods of treating overactive bladder and urinary incontinence
|
AU2006272760A1
(en)
*
|
2005-07-22 |
2007-02-01 |
Myriad Genetics, Inc. |
High drug load formulations and dosage forms
|
DE102005035891A1
(de)
*
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
KR100591142B1
(ko)
*
|
2005-11-04 |
2006-06-20 |
지엘팜텍 주식회사 |
파록세틴을 활성물질로 함유하는 장용성 서방형 정제
|
WO2007054978A2
(en)
*
|
2005-11-10 |
2007-05-18 |
Jubilant Organosys Limited |
Process for preparing paroxetine hydrochloride hemihydrate
|
AU2006315684A1
(en)
*
|
2005-11-14 |
2007-05-24 |
Auspex Pharmaceuticals, Inc. |
Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
|
BRPI0711558A2
(pt)
|
2006-05-04 |
2011-11-08 |
Boeringer Ingelheim Internat Gmbh |
polimorfos
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
WO2008006099A2
(en)
*
|
2006-07-07 |
2008-01-10 |
Myriad Genetics, Inc. |
Treatment of psychiatric disorders
|
WO2008012623A1
(en)
*
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
US20080033050A1
(en)
|
2006-08-04 |
2008-02-07 |
Richards Patricia Allison Tewe |
Method of treating thermoregulatory disfunction with paroxetine
|
EP2118074B1
(en)
|
2007-02-01 |
2014-01-22 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular diseases
|
US20080300258A1
(en)
*
|
2007-05-30 |
2008-12-04 |
Souza Fabio Eduardo Silva |
Anhydrous ciprofloxacin hydrochloride
|
US9138430B2
(en)
*
|
2007-12-27 |
2015-09-22 |
Mylan Specialty L.P. |
Formulation and method for the release of paroxetine in the large intestine
|
PE20091730A1
(es)
|
2008-04-03 |
2009-12-10 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
DE102009030506A1
(de)
*
|
2008-06-30 |
2009-12-31 |
Borgwarner Inc., Auburn Hills |
Reibungsmaterialien
|
KR20190016601A
(ko)
|
2008-08-06 |
2019-02-18 |
베링거 인겔하임 인터내셔날 게엠베하 |
메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
RU2011113823A
(ru)
|
2008-09-10 |
2012-10-20 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
Комбинированная терапия, предназначенная для лечения диабета и связанных с ним состояний
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
KR20110103968A
(ko)
|
2008-12-23 |
2011-09-21 |
베링거 인겔하임 인터내셔날 게엠베하 |
유기 화합물의 염 형태
|
TW201036975A
(en)
|
2009-01-07 |
2010-10-16 |
Boehringer Ingelheim Int |
Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
|
NZ755378A
(en)
|
2009-03-18 |
2022-07-29 |
Resverlogix Corp |
Novel quinazolinones and related compounds for use as anti-inflammatory agents
|
JP2010260826A
(ja)
*
|
2009-05-08 |
2010-11-18 |
Sumitomo Chemical Co Ltd |
パロキセチン塩酸塩半水和物の製造方法
|
MX364651B
(es)
|
2009-11-27 |
2019-05-03 |
Boehringer Ingelheim Int Gmbh Star |
Inhibidores de dpp-iv, tales como la linagliptina, y composiciones farmacéuticas o combinaciones que comprenden los mismos, para usarse en el tratamiento de pacientes diabéticos tipificados genéticamente.
|
EP2566469B1
(en)
|
2010-05-05 |
2022-12-21 |
Boehringer Ingelheim International GmbH |
Combination therapy
|
JP5700367B2
(ja)
*
|
2010-05-06 |
2015-04-15 |
高田製薬株式会社 |
パロキセチン含有フイルムコ−テイング経口製剤
|
EP2585101A1
(en)
|
2010-06-24 |
2013-05-01 |
Boehringer Ingelheim International GmbH |
Diabetes therapy
|
US9034883B2
(en)
|
2010-11-15 |
2015-05-19 |
Boehringer Ingelheim International Gmbh |
Vasoprotective and cardioprotective antidiabetic therapy
|
KR20140045925A
(ko)
|
2011-03-17 |
2014-04-17 |
루핀 리미티드 |
선택적 세로토닌 재흡수 억제제의 방출조절형 약제학적 조성물
|
GB201108345D0
(en)
*
|
2011-05-18 |
2011-06-29 |
Aesica Pharmaceuticals Ltd |
Process
|
MX366629B
(es)
|
2011-07-15 |
2019-07-17 |
Boehringer Ingelheim Int |
Quinazolinas sustituidas, su preparación y su uso en composiciones farmacéuticas.
|
CN102285973B
(zh)
*
|
2011-09-20 |
2013-03-06 |
海南美大制药有限公司 |
一种盐酸帕罗西汀化合物及其制法
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
EP3685839A1
(en)
|
2012-05-14 |
2020-07-29 |
Boehringer Ingelheim International GmbH |
Linagliptin for use in the treatment of albuminuria and kidney related diseases
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
AU2013204159B2
(en)
*
|
2013-03-15 |
2015-05-07 |
Bionomics Limited |
A Crystalline Form of an Anxiolytic Compound
|
EP3110449B1
(en)
|
2014-02-28 |
2023-06-28 |
Boehringer Ingelheim International GmbH |
Medical use of a dpp-4 inhibitor
|
CN104447714A
(zh)
*
|
2014-11-18 |
2015-03-25 |
成都医路康医学技术服务有限公司 |
一种盐酸帕罗西汀的生产工艺
|
WO2017211979A1
(en)
|
2016-06-10 |
2017-12-14 |
Boehringer Ingelheim International Gmbh |
Combinations of linagliptin and metformin
|